FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2936870624> ?p ?o ?g. }

• W2936870624 endingPage "523" @default.
• W2936870624 startingPage "519" @default.
• W2936870624 abstract "To examine the association of preoperative carcinoembryonic antigen (CEA) level with the efficacy of neoadjuvant radiochemotherapy and postoperative metastasis and relapse in patients with rectal cancer.Between January 2011 and January 2014, 325 patients with local advanced rectal cancer underwent preoperative radiochemotherapy and radical operation in Department of Colorectal Cancer Surgery, Beijing University Cancer Hospital, including 194 males and 131 females. According to preoperative MRI, all the patients suffered from clinical T3-4 tumors or positive lymph nodes. Their Zubrod-ECOG-WHO score was 0-1. These patients received preoperative intensity modulated radiotherapy which consisted of 50.6 Gy in 22 fractions (IMRT GTV 50.6 Gy/CTV 41.8 Gy/22 f) with capecitabine(825 mg/m2, twice per day) as radiosensitizer. According to the preoperative serum CEA level, patients were divided into high group (125 cases) and normal group (200 cases). In high group, serum CEA level decreased into normal range in 60 patients (high-normal group) after radiochemotherapy, while it was still in high level in other 65 patients (high-high group). The differences in sensitivity to radiochemotherapy and 3-year disease free survival (DFS) of these patients were both evaluated.In high group and normal group, the complete response rates were 18.4% (23/125) and 17.5% (35/200) (χ2=0.319, P=0.660); the percentages of tumor regression grade(TRG) 0-1 patients were 68.0%(85/125) and 67.5%(135/200)(χ2=0.009, P=0.925); the T downstage rates were 63.2%(79/125) and 70.0%(140/200)(χ2=1.266, P=0.274), respectively, whose differences were all not significant. The 3-year DFS rate in high group was 62.4%, which was significantly lower than 93.5% in normal group (χ2=53.147, P=0.000). There were 65 patients in high-high group, accounting for 52% (65/125) of high group. Among these 65 patients, 44(67.7%) presented recurrence and metastasis within 3 years and the 3-year DFS was 32.3%, which was much lower than 95.0% of 60 patients in high-normal group(χ2=182.085, P=0.000).Preoperative serum CEA level may not be used to predict tumor response of rectal cancer patients who receive preoperative radiochemotherapy. However, the prognosis of patients with high CEA level is worse. Recurrence and metastasis are more likely to occur in patients with high CEA level after radiochemotherapy." @default.
• W2936870624 created "2019-04-25" @default.
• W2936870624 creator A5024762848 @default.
• W2936870624 creator A5039889042 @default.
• W2936870624 creator A5060680269 @default.
• W2936870624 creator A5080849795 @default.
• W2936870624 date "2017-05-25" @default.
• W2936870624 modified "2023-09-27" @default.
• W2936870624 title "[Predictive value of serum carcinoembryonic antigen level in efficacy and prognosis for patients with rectal cancer following preoperative radiochemotherapy]." @default.
• W2936870624 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28534328" @default.
• W2936870624 hasPublicationYear "2017" @default.
• W2936870624 type Work @default.
• W2936870624 sameAs 2936870624 @default.
• W2936870624 citedByCount "0" @default.
• W2936870624 crossrefType "journal-article" @default.
• W2936870624 hasAuthorship W2936870624A5024762848 @default.
• W2936870624 hasAuthorship W2936870624A5039889042 @default.
• W2936870624 hasAuthorship W2936870624A5060680269 @default.
• W2936870624 hasAuthorship W2936870624A5080849795 @default.
• W2936870624 hasConcept C121608353 @default.
• W2936870624 hasConcept C126322002 @default.
• W2936870624 hasConcept C143998085 @default.
• W2936870624 hasConcept C2777387746 @default.
• W2936870624 hasConcept C2777909004 @default.
• W2936870624 hasConcept C2778424827 @default.
• W2936870624 hasConcept C509974204 @default.
• W2936870624 hasConcept C526805850 @default.
• W2936870624 hasConcept C71924100 @default.
• W2936870624 hasConcept C90924648 @default.
• W2936870624 hasConceptScore W2936870624C121608353 @default.
• W2936870624 hasConceptScore W2936870624C126322002 @default.
• W2936870624 hasConceptScore W2936870624C143998085 @default.
• W2936870624 hasConceptScore W2936870624C2777387746 @default.
• W2936870624 hasConceptScore W2936870624C2777909004 @default.
• W2936870624 hasConceptScore W2936870624C2778424827 @default.
• W2936870624 hasConceptScore W2936870624C509974204 @default.
• W2936870624 hasConceptScore W2936870624C526805850 @default.
• W2936870624 hasConceptScore W2936870624C71924100 @default.
• W2936870624 hasConceptScore W2936870624C90924648 @default.
• W2936870624 hasIssue "5" @default.
• W2936870624 hasLocation W29368706241 @default.
• W2936870624 hasOpenAccess W2936870624 @default.
• W2936870624 hasPrimaryLocation W29368706241 @default.
• W2936870624 hasRelatedWork W1983052552 @default.
• W2936870624 hasRelatedWork W2032042555 @default.
• W2936870624 hasRelatedWork W2046824017 @default.
• W2936870624 hasRelatedWork W2110710431 @default.
• W2936870624 hasRelatedWork W2381416288 @default.
• W2936870624 hasRelatedWork W2386824526 @default.
• W2936870624 hasRelatedWork W2404294814 @default.
• W2936870624 hasRelatedWork W2914369221 @default.
• W2936870624 hasRelatedWork W2408888651 @default.
• W2936870624 hasRelatedWork W2547172435 @default.
• W2936870624 hasVolume "20" @default.
• W2936870624 isParatext "false" @default.
• W2936870624 isRetracted "false" @default.
• W2936870624 magId "2936870624" @default.
• W2936870624 workType "article" @default.